Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab. Blood. 2006; 108(8):2648-2654.Bowles JA,Wang SY,Link BK,et al.Anti-CD20monoclonal antibody with enhanced affinity for CD16activates NK cells at lower ...
PIERCEMA133495Anti-CD16 Monoclonal Antibody50 µl2450 厂商 货号 品名 规格 目录价 库存状态 PIERCE MA133495 Anti-CD16 Monoclonal Antibody 50 µl 2450 PIERCE MA133498 Anti-CD20 Monoclonal Antibody 200 µg 5498 PIERCE MA133501 Anti-CD16 Monoclonal Antibody 1 ml 6056 PIERCE MA133502 Anti...
产品名称: FITC anti-Human Lineage Cocktail (CD3, CD14, CD16, CD19, CD20, CD56) .0 订购此产品 供应商: BioLegend 规格: 50 tests 目录价: 7085 库存状态: CAS编号: 应用范围: 种属来源: 相关信息: 保存条件: 说明书地址: 点击查看详细 打印此页 关闭此页 上一个:FITC anti-human IL...
In addition, the FcγRIIIA-optimized LFB-R603 anti-CD20 mAb mediates 100 times greater antibody-dependent cell-mediated cytotoxicity by NK cells from CLL patients and healthy donors than rituximab. Enhanced degranulation against autologous B-CLL cells is observed at lower concentrations of LFB-R...
Bispecific killer cells engagers (BiKEs) which can bind to natural killer (NK) cells through the activating receptor CD16A and guide them to cells expressing the HIV-1 envelope glycoprotein (Env) are a promising new weapon for elimination of infected cel
Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab Leukemia, Lymphocytic, Chronic, B-CellKiller Cells, NaturalGrowing evidence indicates that the affinity of monoclonal antibodies (mAbs) for CD16 (FcgammaR... JA...
PIERCEMA119006Anti-CD16 Monoclonal Antibody100 µg 厂商 货号 品名 规格 目录价 库存状态 PIERCE MA119006 Anti-CD16 Monoclonal Antibody 100 µg 3183 PIERCE MA119007 Anti-CD18 Monoclonal Antibody 100 µg 3183 PIERCE MA119008 Anti-CD20 Monoclonal Antibody 100 µg 3183 PIERCE MA119009 ...
Endogenous IL-8 acts as a CD16 co-activator for natural killer mediated anti-CD20 B cell depletion in chronic lymphocytic leukemia. Leuk Res. 2013;37:440–6.Laprevotte, E., L. Ysebaert, C. Klein, W. Valleron, A. Blanc, E. Gross, G. Laurent, J. J. Fournie´, and A. ...
J. Fournie´, and A. Quillet-Mary. 2013. Endogenous IL-8 acts as a CD16 co-activator for natural killer-mediated anti-CD20 B cell depletion in chronic lymphocytic leukemia. Leuk. Res. 37: 440-446.Laprevotte E, Ysebaert L, Klein C, et al. Endogenous IL-8 acts as a CD16 co-...
In vivo xenograft studies demonstrated that a single low-dose regimen of engineered hnCD16FR iPSC-derived NK cells co-administered with anti-CD20 mAb treatment mediated potent activity and significantly improved survival. Conclusion: We developed a novel hnCD16FR construct that exhibits more potent ...